BRIEF-Aveo Oncology Q3 loss per share $0.07 By: Reuters: Company News November 04, 2016 at 07:27 AM EDT * Says believe that $30.8 million in cash resources could allow to fund planned operations into Q4 of 2017 Read More >> Related Stocks: Aveo Pharmaceuticals